Mariam Dalaty

Dr. Mariam Dalaty


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
MNMihnea Nicodin
Mihnea Nicodin
LNLaura Nicodin-Tigoianu
Laura Nicodin-Tigoianu
APAnca Popescu
Anca Popescu
MDMariam Dalaty
Mariam Dalaty
DBDiana Badiu
Diana Badiu
NSNicolae Suciu
Nicolae Suciu
Background: The total vaginal hysterectomy (TVH) technique has been performed for many gynecological surgeries but is less used than total abdominal hysterectomy (TAH). The purpose of this study was to analyze the outcomes in patients who underwent either TVH or TAH for enlarged diffuse uterine adenomyosis (ADS). Methods: In this retrospective study, 160 hysterectomies with bilateral adnexectomy were scheduled for premenopausal women with diffuse ADS between 2020 and 2024 at a tertiary care center in Romania. The diagnosis was established based on clinical symptomatology, color Doppler transvaginal ultrasound, transabdominal ultrasonography and magnetic resonance imaging with histopathological confirmation of diffuse uterine ADS post-operatively from the hysterectomy specimen. All surgical procedures were performed by the same surgeon. The patients were divided into two groups: the TVH group (n = 80) and the TAH group (n = 80). Patient characteristics, including age, uterine weight, body mass index (BMI), parity, operative time, intraoperative blood loss, length of hospital stay, medical history, surgical history, intra- and postoperative complications, and the presence of adhesions, were evaluated. Results: No differences were observed between the two groups with regard to uterine weight, BMI, or parity. However, the TVH group was associated with significantly younger age, shorter operative time, lower intraoperative blood loss, and a reduced length of hospital stay (p < 0.001). Additionally, both medical and surgical histories were more frequently observed in the TAH group than in the TVH group. However, intra- (i.e., 3.75%) and postoperative complications (i.e., 13.75% vs. 3.75%) were slightly more frequent in the TAH group, as well as adhesions (i.e., 17.50% vs. 8.75%). Uterine hemisection, tactical myomectomy, or morcellation were frequently employed in the TVH group, being required in 77.5% of cases. Conclusions: In our cohort of patients with enlarged diffuse uterine ADS, TVH was associated with younger age, shorter operative time, reduced intraoperative blood loss, and a shorter length hospital stay compared with TAH, without an observed increase in perioperative complications. These results support the use of TVH as a feasible surgical approach for selected enlarged diffuse uterine ADS.

4 February 2026 in Medicina
Verified
Journal Article
Open access
PDF file
MNMihnea Nicodin
Mihnea Nicodin
LNLaura Nicodin-Tigoianu
Laura Nicodin-Tigoianu
APAnca Popescu
Anca Popescu
MDMariam Dalaty
Mariam Dalaty
DBDiana Badiu
Diana Badiu
NSNicolae Suciu
Nicolae Suciu
Background and Objectives: Total vaginal hysterectomy (TVH) has been performed quite often for a uterus with prolapse, although less used than total abdominal hysterectomy (TAH). The purpose of this study was to compare the perioperative outcomes of patients who underwent either TVH or TAH for a uterus with a weight between 250 and 300 g and uterine prolapse (UP). Materials and Methods: In this retrospective study, 180 hysterectomies were planned for women with UP between 2020 and 2024 in a tertiary center in Romania. Patients were diagnosed based on clinical symptomatology and transabdominal ultrasound. All hysterectomies were performed by the same surgeon and were divided into two groups: TVH group (n = 90) and TAH group (n = 90). Patients’ characteristics like age, uterine weight, body mass index (BMI), parity, operative time, intra-operative blood loss, hospital stay, medical history, surgical history, intra- and post-operative complications, and adhesions were evaluated. Results: No significant differences were found between groups in terms of mean age, uterine weight, BMI, or parity. TVH was associated with significantly shorter operative time, lower intra-operative blood loss, and reduced hospital stay compared to TAH (p < 0.001). Both medical and surgical histories were more common in the TAH group compared with the TVH group. However, post-operative complications were slightly more frequent in the TAH group (9.99% vs. 3.33%), as were adhesions (33.33% vs. 13.33%). Uterine hemisection, tactical myomectomy, or morcellation were used in most cases to obtain a reduction in uterine size for the TVH group (81.11%). Conclusions: Our results showed that shorter operating time, lower intra-operative blood loss, and reduced hospital stay support the use of TVH in the case of an enlarged uterus with UP. The present study showed that all patients requiring hysterectomy for such conditions can be offered TVH, which could represent a better therapy option.

Verified
Journal Article
Open access
PDF file
MNMihnea Nicodin
Mihnea Nicodin
TNTudor-Petru Nicodin
Tudor-Petru Nicodin
APAnca Popescu
Anca Popescu
ERElena Rusu
Elena Rusu
Cosmin MoldovanCosmin Moldovan
Cosmin Moldovan
ONOvidiu Nicodin
Ovidiu Nicodin
Patients with a BRCA1 germline mutation often represent a challenge for medical healthcare, since they develop malignancies that tend to be more aggressive and which need to be addressed in multidisciplinary teams with more individualized therapies. We report a case of a 37-year-old woman with a BRCA1 mutation who was diagnosed and treated for high-grade papillary serous carcinoma of the fallopian tube. Eight years later, her regular check-up imaging revealed a latero-aortic lymphadenopathy and a right breast tumor. She underwent a fine needle breast biopsy which was positive for invasive non-specific type carcinoma with negative estrogen, progesterone and Her2 receptors in immunohistochemistry tests. The patient underwent debulking surgery for metastatic lymphadenopathy, followed by chemotherapy with Carboplatin and Paclitaxel, and a modified right mastectomy with axillary lymphadenectomy. She subsequently initiated therapy with the PARP inhibitor Olaparib. No evidence of tumor recurrence was detected during the six-month postoperative follow-up period. The primary goal of this paper is to emphasize the complexity and challenges of managing patients with BRCA1 mutations who develop synchronous malignancies. This case report aims to highlight the increasing role of precision medicine and the importance of personalized, multidisciplinary therapeutic strategies, which include surgery, chemotherapy, and targeted therapies.

1 September 2023 in Journal of Interdisciplinary Medicine
Verified
Journal Article
Open access
PDF file
TITraian Irimia
Traian Irimia
ACAndrada Ioana Crisan
Andrada Ioana Crisan
MCMaria Teodora Cotrus
Maria Teodora Cotrus
VTVlad Andrei Tudorache
Vlad Andrei Tudorache
MDMariam Dalaty
Mariam Dalaty
IMIoana Marta Melinte
Ioana Marta Melinte
Endometriosis is a chronic inflammatory gynecological disease affecting 190 million women or 10% of women of reproductive age worldwide. The disease is marked by the presence of endometrial-like tissue outside the uterus, being associated in many cases with chronic pain and infertility. The current recommendations of international professional societies underline the need for laparoscopy, eventually followed by histological verification, as the gold standard for diagnosis. However, many societies recommend the initiation of specific treatment before obtaining a definitive surgical diagnosis. Various national and international societies have released guidelines for endometriosis assessment based on biomarkers; however, none of these recommendations proved to be clinically useful or able to replace diagnostic laparoscopy. In recent years it was demonstrated that oxidative stress, defined as an imbalance between reactive oxygen species and antioxidants that is directly linked with an increased inflammatory response in the peritoneal cavity, may be involved in the pathophysiology of endometriosis. The identification of a genetic predisposition for endometriosis can identify the patients at risk and may help clinicians promptly initiate therapeutic management of their patients in order to ameliorate their prognosis.

1 July 2026 in Romanian Journal of Military Medicine
Verified
Journal Article
Open access
MNMihnea Andrei Nicodin
Mihnea Andrei Nicodin
LNLaura Nicodin-Tigoianu
Laura Nicodin-Tigoianu
AMAna Elena Martiniuc
Ana Elena Martiniuc
APAnca Popescu
Anca Popescu
AMAlice Elena Munteanu
Alice Elena Munteanu
NSNicolae Suciu
Nicolae Suciu
Cervical cancer remains a major global public health challenge, especially affecting women of reproductive age. In the context of a societal shift towards delayed childbearing, fertility preservation has become an integral component of oncologic care for early-stage disease. Radical trachelectomy has emerged as a viable fertility-sparing surgical option in carefully selected patients. This review aims to assess the role of fertility-sparing radical trachelectomy in the modern management of early-stage cervical cancer by emphasizing the evolving criteria for patient selection, advances in surgical techniques, and the critical balance between oncologic safety and reproductive potential. An analysis of the literature from the past two decades shows that radical trachelectomy, whether performed via vaginal or abdominal routes, provides excellent oncologic control for early-stage lesions. Therefore, optimal results of such a technique depend on careful patient selection along with a multidisciplinary approach in order to reduce obstetrical complications.

1 January 2025 in Chirurgia
Verified
Journal Article
Open access
PDF file
MDMariam Dalaty
Mariam Dalaty
MNMihnea-Andrei Nicodin
Mihnea-Andrei Nicodin
ONOvidiu-Vasile Nicodin
Ovidiu-Vasile Nicodin
LPLucian Puşcaæiu
Lucian Puşcaæiu
MCMihai Emil Capilna
Mihai Emil Capilna
Advanced ovarian cancer is frequently diagnosed at late stages, necessitating precise and individualized treatment strategies. Surgical cytoreduction remains the cornerstone of treatment, with complete macroscopic tumor resection offering the best survival outcomes. However, accurately assessing resectability remains a major challenge. This review aims to evaluate the role of staging laparoscopy in triaging patients with advanced epithelial ovarian cancer, with a focus on its utility in determining surgical resectability and guiding treatment pathways. Emphasis was placed on predictive scoring systems: clinical scores (Suidan score), operative scores (Fagotti, PCI, Eisenkop) and postoperative scores (Aletti). Laparoscopic triage has shown greater predictive accuracy than traditional imaging in evaluating tumor resectability. Scoring systems such as the Fagotti and the Peritoneal Cancer Index provide validated intraoperative frameworks. International guidelines, such as ESMO, ESGO, NCCN, and ASCO, support laparoscopy for preoperative assessment, although its implementation remains limited in some countries, including Romania. Challenges include the lack of standardization, restricted access to advanced laparoscopic infrastructure, and the risk of port-site metastases. Staging laparoscopy is a valuable tool in the management of advanced ovarian cancer, aiding in the selection of optimal treatment strategies. Future integration of radiomics, artificial intelligence, and molecular profiling holds promise for fully personalized patient care.